Cargando…
Dissociable effects of the prodrug phendimetrazine and its metabolite phenmetrazine at dopamine transporters
Phendimetrazine (PDM) is a clinically available anorectic and a candidate pharmacotherapy for cocaine addiction. PDM has been hypothesized to function as a prodrug that requires metabolism to the amphetamine-like monoamine transporter substrate phenmetrazine (PM) to produce its pharmacological effec...
Autores principales: | Solis, Ernesto, Suyama, Julie A., Lazenka, Matthew F., DeFelice, Louis J., Negus, S. Stevens, Blough, Bruce E., Banks, Matthew L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4981850/ https://www.ncbi.nlm.nih.gov/pubmed/27514281 http://dx.doi.org/10.1038/srep31385 |
Ejemplares similares
-
A case of demand ischemia from phendimetrazine
por: Landau, Danny, et al.
Publicado: (2008) -
Preclinical Assessment of Lisdexamfetamine as an Agonist Medication Candidate for Cocaine Addiction: Effects in Rhesus Monkeys Trained to Discriminate Cocaine or to Self-Administer Cocaine in a Cocaine Versus Food Choice Procedure
por: Banks, Matthew L., et al.
Publicado: (2015) -
Preclinical Determinants of Drug Choice under Concurrent Schedules of Drug Self-Administration
por: Banks, Matthew L., et al.
Publicado: (2012) -
Dopamine and Levodopa Prodrugs for the Treatment of Parkinson’s Disease
por: Haddad, Fatma, et al.
Publicado: (2017) -
Understanding the pharmacokinetics of prodrug and metabolite
por: Cho, Seungil, et al.
Publicado: (2018)